SEC 13D/G
NAMS - NewAmsterdam Pharma Company N.V. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified
Keywords
NAMSNAMS SEC filingNAMS institutional investorNewAmsterdam Pharma Company N.V.NewAmsterdam Pharma Company N.V. SEC filingNewAmsterdam Pharma Company N.V. stockSEC 13DSEC 13GThinkSabiostocks simplifiedHealthcareSEC 13D/Gstock market 2026institutional holdings
Share this post
💬 Comments
Loading comments…
Leave a comment
